Today Recommend Impurities of Dapagliflozin
Time:2022-07-22
Views:437
Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. This class of drug uses the kidneys to help control your glucose (blood sugar) levels. It works by increasing the amount of glucose removed from the body when you urinate. It was first approved by the US Food and Drug Administration (FDA) in 2014.
The following are some of the impurities of Dapagliflozin:
The following are some of the impurities of Dapagliflozin: